• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者特定细胞因子表达模式的改变。

Alteration of specific cytokine expression patterns in patients with breast cancer.

机构信息

Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Human Health Sciences, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Sci Rep. 2019 Feb 27;9(1):2924. doi: 10.1038/s41598-019-39476-9.

DOI:10.1038/s41598-019-39476-9
PMID:30814616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6393524/
Abstract

Systemic inflammation has been associated with aggressive tumor growth, invasion, and metastasis. Here we performed a comprehensive analysis of 26 kinds of inflammatory cytokine expression patterns among 185 patients with breast cancer and 54 healthy volunteers followed by chemometric analysis. We identified the specific cytokine expression patterns of breast cancer patients compared to healthy volunteers with (1) VEGF, IL-9, GM-CSF, IL-13, IL-4, and IFNγ, (2) IL-8, IL-10, IL-12, IL-5, IL-7, IL-1α, GCSF, IL-1β, and TNFα and (3) IL-2, Eotaxin, MIP1β, MIP1α, IL-17, and bFGF. Among the patients with breast cancer, we identified the specific cytokine signature of metastatic patients compared to non-metastatic patients. We also established a mathematical model for distinguishing patients with breast cancer from healthy volunteers and metastatic patients from non-metastatic patients. This cytokine network analysis could provide new insights into early intervention and effective therapeutic strategy for patients with breast cancer.

摘要

系统性炎症与侵袭性肿瘤生长、浸润和转移有关。在这里,我们对 185 例乳腺癌患者和 54 名健康志愿者的 26 种炎性细胞因子表达模式进行了综合分析,并进行了化学计量学分析。与健康志愿者相比,我们确定了乳腺癌患者的特定细胞因子表达模式:(1)VEGF、IL-9、GM-CSF、IL-13、IL-4 和 IFNγ;(2)IL-8、IL-10、IL-12、IL-5、IL-7、IL-1α、GCSF、IL-1β 和 TNFα;(3)IL-2、Eotaxin、MIP1β、MIP1α、IL-17 和 bFGF。在乳腺癌患者中,我们确定了转移性患者与非转移性患者的特定细胞因子特征。我们还建立了一个数学模型,用于区分乳腺癌患者和健康志愿者以及转移性患者和非转移性患者。这种细胞因子网络分析可以为乳腺癌患者的早期干预和有效治疗策略提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/04a90cab25e9/41598_2019_39476_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/5d1996c083e3/41598_2019_39476_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/dabfa3adb3ee/41598_2019_39476_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/e01d2b36065c/41598_2019_39476_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/a3acfdd206d4/41598_2019_39476_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/44aa34c2baab/41598_2019_39476_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/04a90cab25e9/41598_2019_39476_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/5d1996c083e3/41598_2019_39476_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/dabfa3adb3ee/41598_2019_39476_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/e01d2b36065c/41598_2019_39476_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/a3acfdd206d4/41598_2019_39476_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/44aa34c2baab/41598_2019_39476_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d0/6393524/04a90cab25e9/41598_2019_39476_Fig6_HTML.jpg

相似文献

1
Alteration of specific cytokine expression patterns in patients with breast cancer.乳腺癌患者特定细胞因子表达模式的改变。
Sci Rep. 2019 Feb 27;9(1):2924. doi: 10.1038/s41598-019-39476-9.
2
Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis.多克隆激活剂对非特殊型浸润性乳腺癌细胞分化和细胞因子产生的影响及其与肿瘤组织病理学参数和淋巴结转移的关系。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420950580. doi: 10.1177/2058738420950580.
3
Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.乳腺浸润性导管癌和纤维腺瘤中肿瘤上清液的细胞因子谱及其与肿瘤中VEGF-A表达的关系。
Int J Immunopathol Pharmacol. 2017 Mar;30(1):83-88. doi: 10.1177/0394632016681306. Epub 2017 Jan 24.
4
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.使用Luminex技术评估接受HER2/neu疫苗的乳腺癌患者的血清细胞因子谱。
Oncol Rep. 2007 Mar;17(3):687-94.
5
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.Notch 介导的肿瘤-基质-炎症网络促进三阴性乳腺癌的侵袭特性和 CXCL8 的表达。
Front Immunol. 2019 Apr 24;10:804. doi: 10.3389/fimmu.2019.00804. eCollection 2019.
6
Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.类风湿关节炎患者足部关节引流的淋巴液有助于深入了解局部细胞因子和趋化因子的产生以及向淋巴结的转运情况。
Arthritis Rheum. 2001 Mar;44(3):541-9. doi: 10.1002/1529-0131(200103)44:3<541::AID-ANR102>3.0.CO;2-6.
7
Oestrogen receptor negative breast cancers exhibit high cytokine content.雌激素受体阴性乳腺癌表现出高细胞因子含量。
Breast Cancer Res. 2007;9(1):R15. doi: 10.1186/bcr1648.
8
[Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].[对非特殊类型浸润性癌及非恶性乳腺疾病患者肿瘤活检样本中细胞因子产生来源的评估]
Biomed Khim. 2019 Aug;65(5):418-423. doi: 10.18097/PBMC20196505418.
9
Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.乳腺癌患者的血清白细胞介素6、血浆血管内皮生长因子、血清血管内皮生长因子及血管内皮生长因子血小板负荷
Clin Breast Cancer. 2002 Jan;2(4):311-5. doi: 10.3816/cbc.2002.n.008.
10
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours.细胞因子信使核糖核酸在正常及肿瘤性人类乳腺组织中的表达:确定白细胞介素-8为乳腺肿瘤中的潜在调节因子。
Int J Cancer. 1997 Sep 17;72(6):937-41. doi: 10.1002/(sici)1097-0215(19970917)72:6<937::aid-ijc3>3.0.co;2-q.

引用本文的文献

1
Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacy.分泌型Clever-1调节T细胞反应并影响癌症免疫治疗效果。
Theranostics. 2025 Jun 23;15(15):7501-7527. doi: 10.7150/thno.110544. eCollection 2025.
2
Mathematical Modeling of Cancer Therapies Demonstrates the Necessity of Both Bacterial Cytotoxicity and Immune Activation.癌症治疗的数学模型表明细菌细胞毒性和免疫激活两者的必要性。
Bioengineering (Basel). 2025 Jul 10;12(7):751. doi: 10.3390/bioengineering12070751.
3
The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.

本文引用的文献

1
Association between serum cytokines and progression of breast cancer in Chinese population.中国人群血清细胞因子与乳腺癌进展的关联
Medicine (Baltimore). 2017 Dec;96(49):e8840. doi: 10.1097/MD.0000000000008840.
2
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系:新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
3
Influence of Circulating Tumour Cells on Production of IL-1α, IL-1β and IL-12 in Sera of Patients with Primary Diagnosis of Breast Cancer Before Treatment.
白细胞介素-2细胞因子家族在黑色素瘤中的多方面作用:机制、治疗意义及免疫调节
J Immunol Res. 2025 Jul 2;2025:8890939. doi: 10.1155/jimr/8890939. eCollection 2025.
4
The role of tumor microenvironment and self-organization in cancer progression: Key insights for therapeutic development.肿瘤微环境和自组织在癌症进展中的作用:治疗开发的关键见解。
Bioimpacts. 2024 Dec 7;15:30713. doi: 10.34172/bi.30713. eCollection 2025.
5
Pro-inflammatory cytokines increase temporarily after adjuvant treatment for breast cancer in postmenopausal women: a longitudinal study.绝经后女性乳腺癌辅助治疗后促炎细胞因子暂时增加:一项纵向研究。
Breast Cancer Res. 2024 Oct 16;26(1):142. doi: 10.1186/s13058-024-01898-3.
6
The cytokine profile correlates with less tumor-infiltrating lymphocytes in luminal A breast cancer.细胞因子谱与腔面A型乳腺癌中较少的肿瘤浸润淋巴细胞相关。
Breast Cancer Res Treat. 2025 Jan;209(2):291-302. doi: 10.1007/s10549-024-07492-7. Epub 2024 Oct 14.
7
The Role of Salivary Vascular Endothelial Growth Factor A, Cytokines, and Amino Acids in Immunomodulation and Angiogenesis in Breast Cancer.唾液血管内皮生长因子A、细胞因子和氨基酸在乳腺癌免疫调节及血管生成中的作用
Biomedicines. 2024 Jun 14;12(6):1329. doi: 10.3390/biomedicines12061329.
8
Progressive, multi-organ, and multi-layered nature of cancer cachexia.癌症恶病质的进行性、多器官和多层次性质。
Cancer Sci. 2024 Mar;115(3):715-722. doi: 10.1111/cas.16078. Epub 2024 Jan 22.
9
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.时间序列血液细胞因子谱与三阴性乳腺癌患者的治疗反应相关。
Br J Cancer. 2024 Apr;130(6):1023-1035. doi: 10.1038/s41416-023-02527-0. Epub 2024 Jan 18.
10
A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel.基于癌症干细胞相关风险评估的乳腺癌分类及免疫图谱分析
NPJ Precis Oncol. 2023 Dec 8;7(1):130. doi: 10.1038/s41698-023-00482-w.
循环肿瘤细胞对初诊乳腺癌患者治疗前血清中IL-1α、IL-1β和IL-12产生的影响。
Anticancer Res. 2016 Oct;36(10):5227-5236. doi: 10.21873/anticanres.11093.
4
Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment.血管生成细胞因子及其对初诊乳腺癌患者治疗前血清中循环肿瘤细胞的影响。
BMC Cancer. 2016 Jul 27;16:547. doi: 10.1186/s12885-016-2612-7.
5
Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer.与乳腺癌相关的外周血免疫细胞中主要免疫调节分子的表达改变。
Breast Cancer. 2017 Jan;24(1):111-120. doi: 10.1007/s12282-016-0682-7. Epub 2016 Mar 4.
6
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.产生白细胞介素-17的γδ T细胞和中性粒细胞共同促进乳腺癌转移。
Nature. 2015 Jun 18;522(7556):345-348. doi: 10.1038/nature14282. Epub 2015 Mar 30.
7
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression.乳腺癌患者骨髓和外周血中播散肿瘤细胞及某些细胞因子水平升高作为肿瘤进展的预测因素。
Exp Oncol. 2013 Dec;35(4):295-302.
8
The roles of TGFβ in the tumour microenvironment.TGFβ 在肿瘤微环境中的作用。
Nat Rev Cancer. 2013 Nov;13(11):788-99. doi: 10.1038/nrc3603. Epub 2013 Oct 17.
9
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.乳腺癌肿瘤微环境中白细胞介素-17 产生细胞浸润是一个不良预后因素。
Histopathology. 2013 Aug;63(2):225-33. doi: 10.1111/his.12156. Epub 2013 Jun 6.
10
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.基于血浆 DNA 测序的癌症治疗获得性耐药的无创分析。
Nature. 2013 May 2;497(7447):108-12. doi: 10.1038/nature12065. Epub 2013 Apr 7.